s6y

Shuttle Pharmaceuticals Holdings, Inc.

Ticker
SHPH
CIK
1757499
Industry
Pharmaceutical Preparations
Formerly
Shuttle Pharmaceuticals Holdings, Inc.

Financials 22

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jun 30, 2026
  4. 10-Q Quarterly Report for period ending Mar 31, 2026
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 22 financials filings

News 104

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K/A Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K/A Current report filing

All 104 news filings

Ownership 59

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 59 ownership filings

Prospectus 45

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-1/A General form of registration statement for all companies including face-amount certificate companies
  6. DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  7. S-1 General form of registration statement for all companies including face-amount certificate companies
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-1 General form of registration statement for all companies including face-amount certificate companies
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 45 prospectus filings

Proxies 21

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  3. DEF 14A Definitive proxy statements
  4. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEF 14A Definitive proxy statements
  9. PRER14A Preliminary revised proxy soliciting materials
  10. DEFR14A Definitive revised proxy soliciting materials

All 21 proxies filings

Other 59

  1. D Exempt (Private) Offering
  2. ARS Annual report to security holders
  3. EFFECT Notice of Effectiveness
  4. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  5. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  6. EFFECT Notice of Effectiveness
  7. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  8. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  9. UPLOAD Letter (PDF)
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 59 other filings